373 related articles for article (PubMed ID: 21116711)
1. Hypertension, left ventricular hypertrophy and chronic kidney disease.
Taddei S; Nami R; Bruno RM; Quatrini I; Nuti R
Heart Fail Rev; 2011 Nov; 16(6):615-20. PubMed ID: 21116711
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.
Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S
J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402
[TBL] [Abstract][Full Text] [Related]
3. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
Schmid H; Schiffl H; Lederer SR
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic cardiovascular risk factors in chronic kidney disease: what are the effects of intervention?
McMahon LP
Semin Dial; 2003; 16(2):128-39. PubMed ID: 12641877
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
8. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
Levin A
Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of etiology and complications in children with stage 5 chronic kidney disease].
Zhong C; Chen YL; Yu XX; Yang Q; Shi YQ; Tan LW; Wang AS; Wu DQ; Zhang GF; Yang HP; Li Q; Wang M
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1109-1117. PubMed ID: 38018048
[No Abstract] [Full Text] [Related]
10. Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.
Martinez-Vea A; Marcas L; Bardají A; Romeu M; Gutierrez C; García C; Compte T; Nogues R; Peralta C; Giralt M
Clin Nephrol; 2012 Mar; 77(3):171-81. PubMed ID: 22377247
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
Rudenko TE; Kutyrina IM; Shvetsov MIu
Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
[TBL] [Abstract][Full Text] [Related]
12. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge.
Levin A
Kidney Int Suppl; 2002 May; (80):35-8. PubMed ID: 11982810
[TBL] [Abstract][Full Text] [Related]
13. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
14. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
[TBL] [Abstract][Full Text] [Related]
15. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
Covic A; Voroneanu L; Goldsmith D
Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
[TBL] [Abstract][Full Text] [Related]
16. Relationships of high cardiac output with ventricular morphology, myocardial energetics, and energy costs in hemodialysis patients with preserved ejection fraction.
Harada T; Obokata M; Kurosawa K; Sorimachi H; Yoshida K; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
Int J Cardiovasc Imaging; 2019 Mar; 35(3):469-479. PubMed ID: 30328027
[TBL] [Abstract][Full Text] [Related]
17. Masked hypertension associates with left ventricular hypertrophy in children with CKD.
Mitsnefes M; Flynn J; Cohn S; Samuels J; Blydt-Hansen T; Saland J; Kimball T; Furth S; Warady B;
J Am Soc Nephrol; 2010 Jan; 21(1):137-44. PubMed ID: 19917781
[TBL] [Abstract][Full Text] [Related]
18. Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients.
Cao C; Hu JX; Dong YF; Zhan R; Li P; Su H; Peng Q; Wu T; Huang X; Sun WH; Wu QH; Cheng XS
Am J Hypertens; 2016 Apr; 29(4):501-8. PubMed ID: 26232035
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J
Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
